151 related articles for article (PubMed ID: 9865493)
1. Selective mRNA degradation by antisense oligonucleotide-2,5A chimeras: involvement of RNase H and RNase L.
Robbins I; Mitta G; Vichier-Guerre S; Sobol R; Ubysz A; Rayner B; Lebleu B
Biochimie; 1998; 80(8-9):711-20. PubMed ID: 9865493
[TBL] [Abstract][Full Text] [Related]
2. Potent gene-specific inhibitory properties of mixed-backbone antisense oligonucleotides comprised of 2'-deoxy-2'-fluoro-D-arabinose and 2'-deoxyribose nucleotides.
Lok CN; Viazovkina E; Min KL; Nagy E; Wilds CJ; Damha MJ; Parniak MA
Biochemistry; 2002 Mar; 41(10):3457-67. PubMed ID: 11876654
[TBL] [Abstract][Full Text] [Related]
3. Correlation of selective modifications to a 2',5'-oligoadenylate-3',5'-deoxyribonucleotide antisense chimera with affinity for the target nucleic acid and with ability to activate RNase L.
Xiao W; Li G; Maitra RK; Maran A; Silverman RH; Torrence PF
J Med Chem; 1997 Apr; 40(8):1195-200. PubMed ID: 9111293
[TBL] [Abstract][Full Text] [Related]
4. Efficient reduction of target RNAs by small interfering RNA and RNase H-dependent antisense agents. A comparative analysis.
Vickers TA; Koo S; Bennett CF; Crooke ST; Dean NM; Baker BF
J Biol Chem; 2003 Feb; 278(9):7108-18. PubMed ID: 12500975
[TBL] [Abstract][Full Text] [Related]
5. Assessment of high-affinity hybridization, RNase H cleavage, and covalent linkage in translation arrest by antisense oligonucleotides.
Gee JE; Robbins I; van der Laan AC; van Boom JH; Colombier C; Leng M; Raible AM; Nelson JS; Lebleu B
Antisense Nucleic Acid Drug Dev; 1998 Apr; 8(2):103-11. PubMed ID: 9593048
[TBL] [Abstract][Full Text] [Related]
6. Sequence-specific RNase H cleavage of gag mRNA from HIV-1 infected cells by an antisense oligonucleotide in vitro.
Veal GJ; Agrawal S; Byrn RA
Nucleic Acids Res; 1998 Dec; 26(24):5670-5. PubMed ID: 9837998
[TBL] [Abstract][Full Text] [Related]
7. Translation of stable hepadnaviral mRNA cleavage fragments induced by the action of phosphorothioate-modified antisense oligodeoxynucleotides.
Hasselblatt P; Hockenjos B; Thoma C; Blum HE; Offensperger WB
Nucleic Acids Res; 2005; 33(1):114-25. PubMed ID: 15640448
[TBL] [Abstract][Full Text] [Related]
8. A short phosphodiester window is sufficient to direct RNase H-dependent RNA cleavage by antisense peptide nucleic acid.
Malchère C; Verheijen J; van der Laan S; Bastide L; van Boom J; Lebleu B; Robbins I
Antisense Nucleic Acid Drug Dev; 2000 Dec; 10(6):463-8. PubMed ID: 11198930
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of double-headed 2-5A-antisense chimeras and their ability to activate human RNase L.
Ueno Y; Okatani S; Yamada Y; Kitade Y
Bioorg Med Chem Lett; 2003 Nov; 13(22):3959-61. PubMed ID: 14592484
[TBL] [Abstract][Full Text] [Related]
10. Site and mechanism of antisense inhibition by C-5 propyne oligonucleotides.
Moulds C; Lewis JG; Froehler BC; Grant D; Huang T; Milligan JF; Matteucci MD; Wagner RW
Biochemistry; 1995 Apr; 34(15):5044-53. PubMed ID: 7536034
[TBL] [Abstract][Full Text] [Related]
11. Antisense phosphorothioate oligonucleotides direct both site-specific and nonspecific RNAse H cleavage of in vitro synthesized p120 mRNA.
Weidner DA; Busch H
Oncol Res; 1994; 6(6):237-42. PubMed ID: 7865899
[TBL] [Abstract][Full Text] [Related]
12. Discrimination between ribonuclease H- and ribonuclease L-mediated RNA degradation by 2'-O-methylated 2-5A-antisense oligonucleotides.
Cramer H; Player MR; Torrence PF
Bioorg Med Chem Lett; 1999 Apr; 9(7):1049-54. PubMed ID: 10230638
[TBL] [Abstract][Full Text] [Related]
13. Catalytic cleavage of an RNA target by 2-5A antisense and RNase L.
Maitra RK; Li G; Xiao W; Dong B; Torrence PF; Silverman RH
J Biol Chem; 1995 Jun; 270(25):15071-5. PubMed ID: 7797490
[TBL] [Abstract][Full Text] [Related]
14. The rates of the major steps in the molecular mechanism of RNase H1-dependent antisense oligonucleotide induced degradation of RNA.
Vickers TA; Crooke ST
Nucleic Acids Res; 2015 Oct; 43(18):8955-63. PubMed ID: 26384424
[TBL] [Abstract][Full Text] [Related]
15. Fast and accurate determination of sites along the FUT2 in vitro transcript that are accessible to antisense oligonucleotides by application of secondary structure predictions and RNase H in combination with MALDI-TOF mass spectrometry.
Gabler A; Krebs S; Seichter D; Förster M
Nucleic Acids Res; 2003 Aug; 31(15):e79. PubMed ID: 12888531
[TBL] [Abstract][Full Text] [Related]
16. Morpholino antisense oligomers: the case for an RNase H-independent structural type.
Summerton J
Biochim Biophys Acta; 1999 Dec; 1489(1):141-58. PubMed ID: 10807004
[TBL] [Abstract][Full Text] [Related]
17. Role of RNase H in hybrid-arrested translation by antisense oligonucleotides.
Walder RY; Walder JA
Proc Natl Acad Sci U S A; 1988 Jul; 85(14):5011-5. PubMed ID: 2839827
[TBL] [Abstract][Full Text] [Related]
18. Potent antisense oligonucleotides to the human multidrug resistance-1 mRNA are rationally selected by mapping RNA-accessible sites with oligonucleotide libraries.
Ho SP; Britton DH; Stone BA; Behrens DL; Leffet LM; Hobbs FW; Miller JA; Trainor GL
Nucleic Acids Res; 1996 May; 24(10):1901-7. PubMed ID: 8657572
[TBL] [Abstract][Full Text] [Related]
19. Increased efficacy of antileishmanial antisense phosphorothioate oligonucleotides in Leishmania amazonensis overexpressing ribonuclease H.
Mishra M; Bennett JR; Chaudhuri G
Biochem Pharmacol; 2001 Feb; 61(4):467-76. PubMed ID: 11226381
[TBL] [Abstract][Full Text] [Related]
20. RNase H is responsible for the non-specific inhibition of in vitro translation by 2'-O-alkyl chimeric oligonucleotides: high affinity or selectivity, a dilemma to design antisense oligomers.
Larrouy B; Boiziau C; Sproat B; Toulmé JJ
Nucleic Acids Res; 1995 Sep; 23(17):3434-40. PubMed ID: 7567453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
